Yh. Chen et al., HIV-1 GP41 BINDING-PROTEINS AND ANTIBODIES TO GP41 COULD INHIBIT ENHANCEMENT OF HUMAN RAJI CELL MHC CLASS-I AND CLASS-II EXPRESSION BY GP41, Molecular immunology, 31(13), 1994, pp. 977-982
Based on our findings, that HIV-1 soluble gp41 could bind to several p
roteins on the human, T, B and monocyte cells independently of CD4, we
examined the effect of HIV-1 soluble gp41 (sgp41; Env amino acids 539
-684) on surface expression of MHC I and II, ICAM-1 and CD21 molecules
on human Raji cells. Flow cytometry (FACS) analysis demonstrated that
sgp41 could selectively enhance MHC class I and II expression on Raji
cells, but did not increase expression of other cell surface antigens
, such as, CD21 and CD54 (ICAM-1). Soluble gp41 could also enhance MHC
class I and II expression on another human B cell line, Bjab. The sgp
41-dependent enhancement of the MHC class I and II expression on Raji
cells is time- and dose-dependent. The sgp41 enhancement effect on the
MHC antigen expression could be inhibited by the gp41-binding protein
s of 45, 49 and 62 kD (isolated from Raji-lysate) which could inhibit
the sgp41-binding to Raji cells. Interestingly, this sgp41-dependent e
nhancement of the MHC class I and II expression could also be inhibite
d by two mAbs to HIV-1 gp41, but not by a third mAb binding to a diffe
rent site on gp41. These results demonstrate that HIV-I sgp41 can sele
ctively enhance the human Raji cell MHC class I and II antigen express
ion and this enhancement effect could be inhibited by the sgp41-bindin
g proteins and anti-gp41 antibodies, and suggest that the sgp41-depend
ent enhancement is mediated by its binding to Raji membrane proteins o
f 45, 49 and 62 kD.